Replies to post #79401 on Biotech Values

[DewDiligence]

TSPT: My question is, what information about the middle of the night dosing instructions did the FDA have questions about? Sounds like something minor to me.

Based on today’s PR, I don’t think investors can infer that the FDA’s concerns are minor. There isn’t sufficient information to make such a determination, IMO.